DEVELOPMENT AND OPTIMIZATION OF FAST DISSOLVING ORAL FILM CONTAINING ARIPIPRAZOLE

Abstract

The present investigation was aimed with the objective of developing fast dissolving oral films of Aripiprazole to attain quick onset of action for the better management of Schizophrenia. Fourteen formulations (F1-F14) of Aripiprazole mouth dissolving films by solvent-casting method using HPMC E5, HPMC E15, Maltodextrin, PG and PVA. Formulations were evaluated for their physical characteristics, thickness, folding endurance, tensile strength, disintegration time, drug content uniformity and drug release characteristics and found to be within the limits. Among the prepared formulations F13 showed minimum disintegration time 10 sec, maximum drug was released i.e. 99.49 ± 0.36% of drug within 8 min when compared to the other formulations and finalized as optimized formulation. FTIR data revealed that no interactions take place between the drug and polymers used in the optimized formulation. The in vitro dissolution profiles of marketed product and optimized formulation was compared and found to be the drug released was 20.73 ± 0.25 after 8 min. Therefore, it can be a good alternative to conventional Aripiprazole for immediate action. In vitro evaluation of the Aripiprazole fast dissolving oral films confirmed their potential as an innovative dosage form to improve delivery and quick onset of action of Aripiprazole. The mouth dissolving film is potentially useful for the treatment of Schizophrenia where the quick onset of action is desired.

Authors and Affiliations

S. Jyothi Sri, D. V. R. N Bhikshapathi

Keywords

Related Articles

ANTI HYPERLIPIDEMIC ACTIVITY OF SPONDIAS PINNATA FRUIT EXTRACTS

Hyperlipidemia is the greatest risk factor of coronary heart disease. Medicinal plants play a major role in hypolipidemic activity. Literature claims that Saponins are able to reduce hyperlipidemia. Based on high saponin...

SENSITIVE AND RAPID HPLC METHOD FOR THE DETERMINATION OF PIOGLITAZONE IN RAT SERUM

A sensitive, accurate and rapid high-performance liquid chromatography with UV-visible detection (HPLC-UV) method for the determination of Pioglitazone in rat serum has been developed. Rosiglitazone was used as internal...

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF LEDIPASVIR AND SOFOSBUVIR IN BULK AND PHARMACEUTICAL DOSAGE FORM

The day by day new combinations drugs are being introduced in market. Then the multiple therapeutic agents which acts at different sites are used in the management of various diseases and disorders are done. Thus it is n...

PROTECTIVE PROPERTIES OF FLAVONOID EXTRACT OF COAGULATED TOFU (CURDLED SOY MILK) AGAINST ACETAMINOPHEN-INDUCED LIVER INJURY IN RATS

The total flavonoid contents of the various coagulated tofu and the hepatoprotective potential of all tofu flavonoid extracts were investigated. Tofu was prepared from locally sourced coagulants (steep water, alum, lemon...

HUTCHINSON-GILFORD PROGERIA SYNDROME: A PREMATURELY AGING DISORDER

Hutchinson-Gilford Progeria Syndrome (HGPS) is an extremely rare genetic disorder characterized by premature aging, involving aberrant splicing of the LMNA gene, resulting in the production of a disease-causing mutant la...

Download PDF file
  • EP ID EP618328
  • DOI 10.25004/IJPSDR.2017.090607
  • Views 85
  • Downloads 0

How To Cite

S. Jyothi Sri, D. V. R. N Bhikshapathi (2017). DEVELOPMENT AND OPTIMIZATION OF FAST DISSOLVING ORAL FILM CONTAINING ARIPIPRAZOLE. International Journal of Pharmaceutical Sciences and Drug Research, 9(6), 327-333. https://europub.co.uk/articles/-A-618328